Cancer treatment threatened by increasingly ineffective antimicrobial drugs

  17 May 2021

As pathogens become ever more resistant to antimicrobial drugs such as antibiotics, people living with cancer run a growing risk of adverse treatment outcomes, including death from an infection, even though their cancer is treatable.

Infections are one of the most common complications that a person living with cancer faces. As many as 1 in 5 cancer patients undergoing treatment are hospitalised due to infection, and antibiotics are the main line of defence.

A study on AMR in the US estimates that a 30% reduction in the efficiency of antibiotics used for cancer patients (in relation to surgery or chemotherapy) would cause an additional 120,000 infections and 6,300 deaths each year.  

Further reading: UICC
Author(s): UICC
Healthy Patients  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!